Nervgen Pharma NGEN
NASDAQ NGEN
$1.43 +0.01 (+0.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Net Income (2025 - 2026)

Updated

Nervgen Pharma (NGEN) posted Net Income of -$21.12 million for the quarter ended Jun 30, 2026, compared with -$6.57 million a year earlier.

Analysis

Nervgen Pharma (NGEN) Net Income (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Income at Nervgen Pharma was -$31.67 million; for the year ended Dec 31, 2025, it was -$31.58 million.

  • In prior years, Nervgen Pharma's Net Income was -$17.71 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 210.00 Mn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.62 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 2.51 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.50 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -248.00 Mn
10 Nervgen Pharma 102.71 Mn 1.59 Mn - -21.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.12 Mn
Mar 31, 2026 -1.22 Mn
Jun 30, 2025 -6.57 Mn
Mar 31, 2025 -2.75 Mn
API Access

Nervgen Pharma Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=NGEN&period=max&api_key=YOUR_API_KEY